ORBIMED ADVISORS LLC
Position in CRBP — Corbus Pharmaceuticals Holdings, Inc.
CIK 1055951
New York, NY
Position in CRBP
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,295,752
-$17,372 QoQ
Shares Held
1,737,287
0.0% QoQ
Ownership
8.98%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#2
of 106 holders
Holding Since
Jun 2020
9 quarters on record
Voting authority
Sole 44%
Shared 0%
None 56%
Common Shares in CRBP Over Time
Shares Held
Position Value (USD)
Derivatives in CRBP
reported options exposure · as of Jun 30, 2020CallValue
$0
CallShares
0
PutValue
$2,936,499
PutShares
11,667
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026ORBIMED ADVISORS LLC holds $3,639,640,835 across 90 Biotechnology names. CRBP ranks #48 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EWTX |
Edgewise Therapeutics, Inc.
|
15,518,492 | $630,516,329 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
6,776,632 | $343,914,074 | |
| 3 | MBX |
MBX Biosciences, Inc.
|
3,428,736 | $189,266,227 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
2,209,400 | $118,578,498 | |
| 5 | SION |
Sionna Therapeutics, Inc.
|
2,555,877 | $112,433,029 | |
| 6 | CRVS |
Corvus Pharmaceuticals, Inc.
|
7,165,006 | $107,045,189 | |
| 7 | AVBP |
ArriVent BioPharma, Inc.
|
3,027,328 | $105,169,374 | |
| 8 | ARGX |
Argenx SE
|
92,880 | $86,171,277 |
All Filings in CRBP
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,295,752 | 1,737,287 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $16,313,124 | 1,737,287 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $13,001,916 | 1,597,287 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $14,829,430 | 1,172,287 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $8,088,780 | 1,172,287 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,224,843 | 1,172,287 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $8,474,760 | 718,200 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $13,832,986 | 1,172,287 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $18,825,947 | 912,552 | Shares | Defined | 2024-11-14 | |
| 2020-06-30 | $2,936,499 | 350,000 | Put | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||